REmAb® de novo Antibody Sequencing by Mass Spectrometry from RAPID NOVOR INC.

Search, find, compare suppliers for REmAb® de novo Antibody Sequencing by Mass Spectrometry products.

Edit 
Product NameREmAb® de novo Antibody Sequencing by Mass Spectrometry
DescriptionThe REmAb® de novo antibody sequencing workflow delivers the complete antibody sequence, including CDRs, with unparalleled accuracy and reliability. Starting with just 100µg of purified antibody, the sample undergoes multi-enzyme digestions and the fragments are measured with LC-MS/MS to derive the de novo peptide sequences. These fragments are then analyzed by Rapid Novor's suite of bioinformatics algorithms to assemble the full-length antibody sequences of any isotype. Our unique de novo workflow allows us to determine the full antibody sequence with hundreds of overlapped peptides without requiring a database or sequence library for reference or homology.
Sizen/a
Concentrationn/a
Applicationsn/a
Other Namesn/a
Gene, Accession, CAS #n/a
Catalog #n/a
Priceplease inquire
Order / More InfoREmAb® de novo Antibody Sequencing by Mass Spectrometry from RAPID NOVOR INC.
Product Specific Referencesn/a
RAPID NOVOR INC.
RAPID NOVOR INC.
RAPID NOVOR INC.
137 Glasgow St, Unit 450
Kitchener, ON N2G 4X8 CANADA
P: 1-855-899-9990

info@rapidnovor.com

http://www.rapidnovor.com

Profile of RAPID NOVOR INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.